These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32300817)

  • 21. Urologic cancer in China.
    Pang C; Guan Y; Li H; Chen W; Zhu G
    Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Landscape of Immunotherapy in Genitourinary Malignancies.
    Ravindranathan D; Alhalabi O; Rafei H; Shah AY; Bilen MA
    Adv Exp Med Biol; 2021; 1342():143-192. PubMed ID: 34972965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer.
    Soria F; Beleni AI; D'Andrea D; Resch I; Gust KM; Gontero P; Shariat SF
    World J Urol; 2018 Nov; 36(11):1703-1709. PubMed ID: 29549485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature.
    Guler OC; Bal N; Onal C
    Clin Genitourin Cancer; 2016 Apr; 14(2):e211-3. PubMed ID: 26739102
    [No Abstract]   [Full Text] [Related]  

  • 25. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of primary urothelial carcinoma of the prostate].
    Yamauchi H; Tsuka H; Muranaka K
    Hinyokika Kiyo; 2006 Dec; 52(12):959-60. PubMed ID: 17252982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of primary transitional cell carcinoma of the prostate].
    Konya E; Nose K; Kiwamoto H; Kataoka K; Kajikawa H; Kurita T
    Hinyokika Kiyo; 1999 Jun; 45(6):439-42. PubMed ID: 10442290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
    Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
    Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transitional cell carcinoma of the prostate.
    Algaba F; Santaularia JM; Lamas M; Ayala G
    Eur Urol; 1985; 11(2):87-90. PubMed ID: 3891355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urologic cancer in Thailand.
    Lojanapiwat B
    Jpn J Clin Oncol; 2015 Nov; 45(11):1007-15. PubMed ID: 26355159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple synchronous genitourinary malignancies of dissimilar histogenesis.
    Wentworth SA; Head RW; Stewart R
    Urology; 1985 Mar; 25(3):313. PubMed ID: 3976123
    [No Abstract]   [Full Text] [Related]  

  • 34. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
    Hardeman SW; Perry A; Soloway MS
    J Urol; 1988 Aug; 140(2):289-92. PubMed ID: 3135420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bibliography. Current world literature. Genitourinary systems.
    Curr Opin Oncol; 2000 May; 12(3):B104-33. PubMed ID: 10841204
    [No Abstract]   [Full Text] [Related]  

  • 37. Open clinical uro-oncology trials in Canada.
    Mackenzie M; Rodrigues G; Winquist E
    Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993
    [No Abstract]   [Full Text] [Related]  

  • 38. Nuclear p53 overexpression in bladder, prostate, and renal carcinomas.
    Sinik Z; Alkibay T; Ataoglu O; Biri H; Sözen S; Deniz N; Karaoglan U; Bozkirli I
    Int J Urol; 1997 Nov; 4(6):546-51. PubMed ID: 9477181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers in the histopathology of urologic tumors].
    Hofstädter F
    Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
    Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
    Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.